Biotech China Currency Donald Trump Healthcare Investment Medicine Revenue stock market Tariff Technology Vaccine
How this Trump appointee could pressure the CSL share price You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources , and more. Learn More The CSL Ltd (ASX: CSL) share price is enjoying a welcome rebound today. That’s after shares got hammered amid the broader Trump tariff stock market sell-off over the past few trading days. Shares in the S&P/ASX 200 Index (ASX: XJO) biotech stock closed yesterday trading for $241.88. In afternoon…
News Timeline:
Track the development of related news across the Internet.
July 19, 2025
07:10
Source: billboard.com
June 11, 2025
09:03
Source: fool.com.au
April 14, 2025
05:20
Source: fool.com.au
March 17, 2025
07:43
Source: fool.com.au
February 25, 2025
08:05
Source: fool.com.au